Trade BCDA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BioCardia, Inc. (BCDA) is trading at US$1.09, down 1.36% today as of Sep 10, 11:49 EDT. The company has a market capitalisation of US$15.29M. Over the past 52 weeks, BCDA has traded between US$0.75 and US$2.29. On Syfe you can trade BCDA with $0 commission and add it to your watchlist.
| Previous close | US$1.10 |
|---|---|
| Market cap | US$15.29M |
| 52-week range | US$0.75 – US$2.29 |
| Volume | 91.02K |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioCardia, Inc.
BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and AVANCE Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Year: 1995
Sector Update: Healthcare Stocks Higher Late Afternoon
Jun 5, 7:49 PM · MT Newswires
Sector Update: Healthcare Stocks Gain Friday Afternoon
Jun 5, 5:50 PM · MT Newswires
Top Midday Gainers
Jun 5, 5:29 PM · MT Newswires
Sector Update: Healthcare Stocks Rise Premarket Friday
Jun 5, 1:23 PM · MT Newswires
BioCardia Says US FDA Confirms Heart Failure Trial May Support Premarket Approval for CardiAMP System
Jun 5, 12:41 PM · MT Newswires
BioCardia, Inc. (BCDA) stock is trading at US$1.09, -1.36% from the previous close of US$1.10.
The market cap for BioCardia, Inc. (BCDA) stock is approximately US$15.29M.
The 52-week high for BioCardia, Inc. (BCDA) stock is US$2.29.
The 52-week low for BioCardia, Inc. (BCDA) stock is US$0.75.
BioCardia, Inc. (BCDA) does not currently pay a dividend.
Stay on top of BCDA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
